9-128170094-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001131016.2(CIZ1):āc.1957A>Cā(p.Arg653=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0215 in 1,605,114 control chromosomes in the GnomAD database, including 462 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.020 ( 36 hom., cov: 33)
Exomes š: 0.022 ( 426 hom. )
Consequence
CIZ1
NM_001131016.2 synonymous
NM_001131016.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.16
Genes affected
CIZ1 (HGNC:16744): (CDKN1A interacting zinc finger protein 1) The protein encoded by this gene is a zinc finger DNA binding protein that interacts with CIP1, part of a complex with cyclin E. The encoded protein may regulate the cellular localization of CIP1. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 9-128170094-T-G is Benign according to our data. Variant chr9-128170094-T-G is described in ClinVar as [Benign]. Clinvar id is 413832.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-128170094-T-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=1.16 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.02 (2870/143754) while in subpopulation AMR AF= 0.0286 (381/13318). AF 95% confidence interval is 0.0264. There are 36 homozygotes in gnomad4. There are 1373 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2870 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CIZ1 | NM_001131016.2 | c.1957A>C | p.Arg653= | synonymous_variant | 12/17 | ENST00000372938.10 | NP_001124488.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CIZ1 | ENST00000372938.10 | c.1957A>C | p.Arg653= | synonymous_variant | 12/17 | 1 | NM_001131016.2 | ENSP00000362029 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0200 AC: 2871AN: 143632Hom.: 36 Cov.: 33
GnomAD3 genomes
AF:
AC:
2871
AN:
143632
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0189 AC: 4677AN: 248022Hom.: 59 AF XY: 0.0196 AC XY: 2636AN XY: 134326
GnomAD3 exomes
AF:
AC:
4677
AN:
248022
Hom.:
AF XY:
AC XY:
2636
AN XY:
134326
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0216 AC: 31592AN: 1461360Hom.: 426 Cov.: 32 AF XY: 0.0217 AC XY: 15746AN XY: 727022
GnomAD4 exome
AF:
AC:
31592
AN:
1461360
Hom.:
Cov.:
32
AF XY:
AC XY:
15746
AN XY:
727022
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0200 AC: 2870AN: 143754Hom.: 36 Cov.: 33 AF XY: 0.0197 AC XY: 1373AN XY: 69638
GnomAD4 genome
AF:
AC:
2870
AN:
143754
Hom.:
Cov.:
33
AF XY:
AC XY:
1373
AN XY:
69638
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
19
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Dystonic disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at